IGENE BIOTECHNOLOGY INC (CIK: 0000793160) EDGAR, Information, Filings... CompaniesBIO.Com

IGENE BIOTECHNOLOGY INC

Mailing address
9110 RED BRANCH ROAD, SUITE J, COLUMBIA, Maryland, 21045-2024
Phone
4109972599
State location
Maryland
State of incorporation
Maryland
Fiscal year end
December 09
SIC
2870 - (CF Office: Office of Life Sciences) AGRICULTURAL CHEMICALS
Filings
N/A

IGENE BIOTECHNOLOGY INC (CIK: 0000793160) is an American company incorporated in the state of Maryland. Head office is located at 9110 RED BRANCH RD, SUITE J, COLUMBIA, Maryland, 21045-2024. Work in the industry 2870 - (CF Office: Office of Life Sciences) AGRICULTURAL CHEMICALS. IGENE BIOTECHNOLOGY INC is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
ABELES JOSEPH C	0001243684	Mar-23-2006	10 percent owner, other: Resigned as Director 7/31/2002
HIU STEPHEN F	0001272098	Jun-25-2004	director, officer: President
WEISEBERGER EDWARD J	0001287805	Jun-25-2004	officer: Chief Financial Officer
KIMELMAN MICHAEL	0001158984	Dec-31-2003	director
MONAHAN PATRICK F	0001242871	Dec-03-2003	director, officer: Secretary
KEMPNER THOMAS L	0001091925	Feb-28-2003	director, 10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by IGENE BIOTECHNOLOGY INC

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000766050-17-000006 (34 Act) Size: KB	Apr-10-2017	005-38782 17752192
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000766050-17-000005 (34 Act) Size: KB	Apr-07-2017	005-38782 17749748
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000766050-17-000002 (34 Act) Size: KB	Jan-10-2017	005-38782 17520289
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0000793160-11-000002 (34 Act) Size: KB	Mar-15-2011	000-15888 11688456
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000793160-10-000008 (34 Act) Size: KB	Nov-15-2010	000-15888 101189322
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001158984-10-000001 ( Act) Size: 0 KB	Oct-21-2010
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000793160-10-000006 (34 Act) Size: KB	Aug-13-2010	000-15888 101015075
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000793160-10-000004 (34 Act) Size: KB	May-14-2010	000-15888 10833450
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0000793160-10-000002 (34 Act) Size: KB	Mar-31-2010	000-15888 10718167
8-K	Document	Current report filing Acc-no: 0000793160-09-000012 (34 Act) Size: KB	Dec-01-2009	000-15888 091213838
DEF 14C	Document	Definitive information statements Acc-no: 0001026608-09-000170 (34 Act) Size: KB	Nov-24-2009	000-15888 091205286
PRE 14C	Document	Preliminary information statement not related to a contested matter or merger/acquisition Acc-no: 0001026608-09-000165 (34 Act) Size: KB	Nov-13-2009	000-15888 091181973
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000793160-09-000010 (34 Act) Size: KB	Nov-13-2009	000-15888 091180314
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000793160-09-000008 (34 Act) Size: KB	Aug-14-2009	000-15888 091013898
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001158984-09-000001 ( Act) Size: 0 KB	Jul-23-2009
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001242871-09-000001 ( Act) Size: 0 KB	Jul-23-2009
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001287805-09-000001 ( Act) Size: 0 KB	Jul-23-2009
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001272098-09-000001 ( Act) Size: 0 KB	Jul-23-2009
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000793160-09-000006 (34 Act) Size: KB	May-15-2009	000-15888 09829536
NT 10-K	Document	Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0000793160-09-000004 (34 Act) Size: KB	Apr-01-2009	000-15888 09723222

Recent 20 filings. View all IGENE BIOTECHNOLOGY INC filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

IGENE BIOTECHNOLOGY INC overview
IGENE BIOTECHNOLOGY INC job
IGENE BIOTECHNOLOGY INC stock
IGENE BIOTECHNOLOGY INC ownership
IGENE BIOTECHNOLOGY INC CEO
IGENE BIOTECHNOLOGY INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.